Get The Alerts + Report

LAVA Therapeutics NV [LVTX]

Reporting date: 10/08/2025

⚠️ Neutral Insider Sale Detected

📝 What Happened

  • Insider: Gilde Healthcare Holding B.V.
  • Role: 10% Owner
  • Company: LAVA Therapeutics NV (LVTX)
  • Transaction Date(s): 2025-10-08, 2025-10-09, 2025-10-10
  • Table I (Non-Derivative Securities)
    • Sale : 126,992 shares
    • Average Sale Price: $1.57, $1.56, $1.55 (weighted average ≈ $1.56)
    • Total Value: 126,992 * $1.56 ≈ ~$197,898
    • Post-Transaction Direct Holdings: 5,294,178 shares
    • Indirect Holdings: None reported
    • 10b5-1 Plan Used? No

    📄 Summary

    Gilde Healthcare Holding B.V., 10% Owner at LAVA Therapeutics NV (LVTX), sold 126,992 shares on October 8–10, 2025, at an average price of $1.56, realizing proceeds of about ~$197,898. After the transaction, it now holds 5,294,178 direct shares; no indirect holdings reported. For retail traders, this is a neutral-to-slightly bearish event: modest sized sale likely profit-taking by a large holder.

    🔑 Interpretation

    This appears to be a discretionary sale by a 10% owner (transaction code S, aff10b5One = false). Shares were sold across three consecutive days and realized modest proceeds; the transactions reduced direct holdings by roughly 2–3% of the position. The price of the sales (~$1.55–$1.57) is not near a reported all-time high and is closer to the lower end of recent trading, suggesting these were not timed to an extreme high; the activity looks like routine liquidity/profit-taking rather than a clear negative signal. The sale size is not unusually large relative to the holder’s remaining position.

    🔑 Interpretation

    • Type: Discretionary (not a 10b5-1 plan; transaction code S)
    • Disposition: Shares were sold (disposed) immediately across executed trades on three dates
    • Size Context: The sale of 126,992 shares is modest versus post-transaction direct holdings of 5.29M shares (~2–3% of the position) — consistent with routine profit-taking rather than a material exit
    • ATH Metric: Using the sale price range (~$1.55–$1.57) as a recent price reference, the trades did not occur near obvious all-time highs and sit closer to lower historical levels; timing appears opportunistic for liquidity rather than taking advantage of peak prices
    • Outlier Check: Not unusually large compared to the holder’s position; no evidence here of anomalously large single-day disposition

    📊 Bullish or Bearish?

    Decide: Neutral → Slightly Bearish

    Neutral → Slightly Bearish. A 10% owner executed a series of non-derivative sales (codes S) totaling 126,992 shares, realizing modest proceeds; the holder retains the vast majority of its position. The pattern and disclosure (no 10b5‑1) point to routine liquidity/profit-taking rather than a definitive negative signal. Data is limited to these non-derivative sales and does not show clustered insider exits.

    ✅ Bottom Line (Retail Takeaway)

    This transaction looks like routine profit-taking rather than a strong bearish signal. For retail traders, it’s likely noise — not a clear trade trigger on its own and not worth short-/mid-term action unless corroborated by large sales from multiple insiders or other negative company-specific news.